Applied Therapeutics (APLT) announced the appointment of Todd Baumgartner, MD, MPH as Chief Regulatory Officer. Dr. Baumgartner will serve as part of the Company’s executive leadership team and will be responsible for leading Applied’s global regulatory strategy. Prior to joining Applied, Dr. Baumgartner served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilance and Biometrics at Ovid Therapeutics (OVID) from 2020 through 2024
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT: